ArticleThe journal of obstetrics and gynaecology research2021
Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan.
Article in The journal of obstetrics and gynaecology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 24 citations in OpenAlex.
- Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension.Computational and mathematical methods in medicine · 2022Trial
- Safety of COVID-19 Vaccination in Pregnancy: A Systematic Review.Diagnostics (Basel, Switzerland) · 2024Review
- COVID-19 vaccine registry for pregnant women: policy to control complications of vaccination in pregnant women in 2021-2022.BMC pregnancy and childbirth · 2023Article
- Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023Observational
- COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan.Vaccine · 2022Article
- Impact of health literacy on anxiety and depressive symptoms in pregnant women in Japan during the COVID-19 pandemic.Scientific reports · 2022Article
- C-reactive protein level predicts need for medical intervention in pregnant women with SARS-CoV2 infection: A retrospective study.The journal of obstetrics and gynaecology research · 2022Article
- COVID-19 vaccine and pregnancy: A safety weapon against pandemic.Taiwanese journal of obstetrics & gynecology · 2022Review
- Cross-Sectional Survey of High-Risk Pregnant Women's Opinions on COVID-19 Vaccination.Women's health reports (New Rochelle, N.Y.) · 2022Article
- Article
- Importance to release of the number of pregnant women with COVID-19 to help build the perinatal medical care system in Japan.The journal of obstetrics and gynaecology research · 2021Article
- Exploring and Monitoring the Reasons for Hesitation with COVID-19 Vaccine Based on Social-Platform Text and Classification Algorithms.Healthcare (Basel, Switzerland) · 2021Article
- Alignment of national COVID-19 vaccine recommendations for pregnant and lactating women.Bulletin of the World Health Organization · 2021Article
- Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective.Rheumatology international · 2021Article
- COVID19 Vaccination Considerations for Pregnant Women: A Systematic Review.Iranian journal of nursing and midwifery researchReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
The current COVID-19 pandemic is a global concern. The recent introduction of vaccines has provided a reason for hope, but new problems, such as vaccine hesitancy, have arisen. One of the most important of these issues is the safety of vaccines for pregnant women. In this article, we collected worldwide indications for vaccination, including women who are pregnant or who wish to become pregnant, and reports of adverse reactions to COVID-19 vaccination. The Japan Society of Obstetrics and Gynecology and the Japanese Society of Infectious Diseases in Obstetrics and Gynecology have published recommendations for the vaccination of pregnant women with a COVID-19 vaccine. The guidelines are as follows: (1) pregnant women should not be excluded from vaccination; (2) informed consent should be obtained before vaccination; (3) healthcare workers and pregnant women with complications such as diabetes, hypertension, and obesity should be vaccinated preferentially; (4) vaccination should be avoided until 12 weeks of gestation during organogenesis; (5) spouse and family members should be vaccinated actively; and (6) nursing mothers are not particularly affected. This policy has been adopted in government guidelines. Additional efforts should be made to protect pregnant women from infection and severe illness with COVID-19 by eliminating vaccine hesitancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.